Literature DB >> 1554270

Operation for cavitating invasive pulmonary aspergillosis in immunocompromised patients.

V K Young1, H A Maghur, D A Luke, E M McGovern.   

Abstract

Invasive pulmonary aspergillosis is a specific form of pulmonary Aspergillus infection that occurs almost exclusively in immunocompromised patients. It differs both histologically and in its clinical course from classic aspergillomas. During a 5-year period (1986-1990), 8 patients underwent resection for cavitating invasive pulmonary aspergillosis that developed as a consequence of neutropenia during chemotherapy for malignancy. There were no perioperative deaths and no complications. This contrasts with reports of operation for classic aspergillomas. Histologic examination of the resected specimens showed that cavitating invasive pulmonary aspergillosis differed from classic aspergillomas. They consisted of necrotic lung tissue invaded by fungus with separation from the surrounding lung so that the sequestrum had the appearance of a fungus ball. Pulmonary aspergillosis is a common complication of profound neutropenia. The first hemoptysis in this group of patients is often life-threatening. The excellent results of operation in our series of patients may be attributed to their young age, good pulmonary function, and limited operation. This has lead us to recommend early surgical intervention in invasive aspergillosis once cavitation develops.

Entities:  

Mesh:

Year:  1992        PMID: 1554270     DOI: 10.1016/0003-4975(92)90321-t

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

Review 1.  Aspergilloma and the surgeon.

Authors:  Loven Moodley; Jehron Pillay; Keertan Dheda
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

2.  Surgery of pulmonary aspergillomas in immunocompromised patients.

Authors:  B Kosan; V Steger; T Walker; G Friedel; H Aebert
Journal:  Thorac Surg Sci       Date:  2010-03-10

3.  Surgical resection for patients with pulmonary aspergillosis in the national inpatient sample.

Authors:  Deven C Patel; Prasha Bhandari; David J Epstein; Douglas Z Liou; Leah M Backhus; Mark F Berry; Joseph B Shrager; Natalie S Lui
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.